STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: That is to say, initiating from abnormal expression and activation of STAT5A, dysregulation of STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis exerts an critical role in CML cells apoptosis Imatinib resistance.